T cell

(redirected from T-cells)
Also found in: Dictionary, Medical, Encyclopedia.
Related to T-cells: Cytokines, B-cells
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for T cell

References in periodicals archive ?
Immuno-imaging of tumor-infiltrating CD8 T-cells with radiolabeled antibody fragments could provide a specific and sensitive modality to achieve this goal.
Researchers are now developing gene therapy that would boost the production of LEM protein, increasing the number of T-cells to attack cancer cells.
Memory T-cells in babies are more active, faster and quicker than adults with more strength on dealing pathogens.
When patients were taken off their meds for four weeks, the number of unprotected T-cells still in the body fell dramatically, whereas the modified T-cells appeared protected and could still be found in the blood several months later.
During cultivation, the T-cells are stimulated with growth factors and re-activated with antigen from the patient's individual tumor.
Higher levels of autoreactive T-cells, which have the ability to turn on the body, could explain why babies born in May are at a higher risk of developing MS.
Our findings show how killer T-cells might play an important role in auto-immune diseases like diabetes and we've secured the first ever glimpse of the mechanism by which killer T-cells can attack our own body cells to cause disease.
Because cancer cells are usually normal, healthy cells, which have malfunctioned in some way, self-tolerance can limit the ability of T-cells to react against, and kill, tumours.
The new research involved T-cells from more than 1,000 patients with type 1 diabetes, other autoimmune disorders, and healthy volunteers.
T-cells recognize the antigens on MHC-I or -II for activation to further modulate macrophage functions resulting in either inhibition or augmentation of intracellular M.
As a result, when a bispecific antibody complex binds to healthy tissue away from light, it cannot activate T-cells.
AdapT technology uses proprietary two-peptide molecular constructs to selectively cause the death of only those immune T-cells that are involved in autoimmune disease, asthma, allergy, and transplant rejection, by having these disease causing T-cells undergo apoptosis (programmed cell death) and anergy (a state of immune unresponsiveness).
Memory cells make up more than half of T-cells in adults, and early in HIV disease many of these cells are infected and eventually lost.
T-cells failed to internalize either of the particulates and showed no organelle or nuclear changes.
According to a recent study, COPAXONE(R) stimulates T-cells to produce the neuroprotection factor BDNF (brain-derived neurotrophic factor) in tissue culture using T-cells from a COPAXONE(R) patient.